1.1Shielding for external photons
A lead-lined panel sits between the X-ray source and the subject. Lead thickness is selected for the photon energy range, and a dosimeter on the subject side measures the transmitted dose.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A lead-lined panel sits between the X-ray source and the subject. Lead thickness is selected for the photon energy range, and a dosimeter on the subject side measures the transmitted dose.
A motorized gripper transfers the sealed source while the operator remains at a separate control station. For a compact source in open geometry, doubling the distance reduces the direct dose rate to approximately one-quarter.
Oral capsules release insoluble ferric hexacyanoferrate into the gastrointestinal tract. The solid binds cesium in the gut, interrupts its reabsorption, and increases its elimination in stool.
A subcutaneous formulation delivers a recombinant protein that activates receptors on surviving myeloid progenitor cells and promotes neutrophil production. Serial blood counts track the absolute neutrophil count during recovery.
The tray holds separately sealed components with identity and lot labels. The clinician selects and releases each component against an individualized order in the patient record.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A veterinary referral hospital uses a three-compartment kit in exercises for simulated radiation incidents involving animals. The compartments contain sealed training units and carry labels for protection, mitigation, and recovery. An instructor issues simulated exposure and assessment records, and trainees select the matching compartment and record each handoff.
A passive near-field communication tag replaces the printed instruction booklet on the kit lid. The tag stores a link to a versioned instruction file that a handheld reader caches for offline access. The file presents the three stages in order and uses the same identifiers as the compartment labels.
A transport case holds 12 removable trays in a three-by-four rack. Each tray has three lidded compartments arranged in a fixed order for protection, mitigation, and recovery. The tray and its three compartments share a serial number, and a removable card records the issue and return times for that tray.
The pharmacy inventory system stores the outer kit as a parent record and the three stage packages as child records. Each package carries a two-dimensional barcode, and its inventory record stores the lot number, expiration date, and storage location. Scanning a stage package at issue updates the parent kit record and places the kit on a replenishment list.
A drill application stores a simulated exposure timestamp and three instructor-configured prompt times relative to that timestamp. At each prompt, the application displays the corresponding stage label and requests a scan of the matching training compartment. It logs the scan time and flags a mismatch between the scanned compartment and the scheduled stage.
A battery-powered temperature logger clips inside the outer case and records a timestamped reading every five minutes. Inventory software compares the readings with the storage limits recorded for each of the three stage packages. The software lists the affected package identifiers and the duration of each temperature excursion on the kit inspection screen.
Each soft gelatin capsule contains 500 mg of sea buckthorn oil as a liquid fill. An opaque foil blister encloses each capsule and limits light exposure during storage.
Each foil-laminate sachet contains 1 g of sodium phenylbutyrate powder in a factory-measured fill. The sachet label identifies the salt form and the mass of that salt per unit.
A folded card contains separate rows for pre-exposure use, early post-exposure use, and follow-up. Each row identifies the corresponding component and provides fields for recording the exposure time and administration time.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
A plant-extracted oil oral supplement comprising: a combination of sea buckthorn oil with at least one phytonutrient to reload adipocytes; palmitelaidic acid from sea buckthorn fruit oil and epigallocatechin from sea buckthorn seed oil and/or sea buckthorn pulp oil to improve conversion of calcium ATP-ase to magnesium ATP-ase and facilitate absorption of epigallocatechin (EPCG) into adipocytes; wherein the supplement is administered over about a 3 month cycle at about 2 tableB · US 2022/0118041 A1 · claim 12
A commercial embodiment of this technology is an oral dose powder packet of sodium phenylbutyrate marketed by ForTe Beheer B V (The Netherlands).A · US 2006/0045912 A1 · ¶ 14
An empty cell means only that no passage was reproduced there.
The invention provides controlled-release pharmaceutical formulations of 4-phenylbutyric acid and its pharmaceutically acceptable salts, solvates, esters and prodrugs for therapeutic use.A · US 2006/0045912 A1 · ¶ 2
Controlled-release 4-phenylbutyric acid formulations are useful in the treatment of various disorders, including cancer (e.g., prostate cancer) and neurodegenerative diseases (e.g., spinal muscular atrophy, amyotrophic lateral sclerosis).A · US 2006/0045912 A1 · ¶ 2
A vast majority of health conditions and even diseases are the direct result of specific nutrient shortages that come about from chronic inflammation, toxicity, pathogen utilization, infection, and/or poor dietary habits.B · US 2022/0118041 A1 · ¶ 2
Benefits may include, but are not limited to, repair of fat pad atrophy in the face and body, the treatment of high cholesterol, the treatment of diabetes, the clearance of allergies, improvements in high blood pressure, the improvement of skin conditions like acne, eczema, psoriasis, seborrheic dermatitis, perioral dermatitis, improvements in astigmatism, and more.B · US 2022/0118041 A1 · ¶ 6
patent.fyi, US 2026/0355233 A1, claim 1, first published 2026-11-19T09:44:02-05:00, https://patent.fyi/US20260355233/, SHA-256 ed42bb0c920b6a9667a6afd3a96dd9c470649c670646efe5723920d973e3ffbe